1. Home
  2. VS vs LYRA Comparison

VS vs LYRA Comparison

Compare VS & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VS
  • LYRA
  • Stock Information
  • Founded
  • VS 2013
  • LYRA 2005
  • Country
  • VS United States
  • LYRA United States
  • Employees
  • VS N/A
  • LYRA N/A
  • Industry
  • VS EDP Services
  • LYRA Medical/Dental Instruments
  • Sector
  • VS Technology
  • LYRA Health Care
  • Exchange
  • VS Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • VS 9.6M
  • LYRA 11.3M
  • IPO Year
  • VS N/A
  • LYRA 2020
  • Fundamental
  • Price
  • VS $2.08
  • LYRA $6.35
  • Analyst Decision
  • VS Hold
  • LYRA Hold
  • Analyst Count
  • VS 1
  • LYRA 1
  • Target Price
  • VS $2.00
  • LYRA $16.00
  • AVG Volume (30 Days)
  • VS 319.6K
  • LYRA 14.7K
  • Earning Date
  • VS 08-14-2025
  • LYRA 11-11-2025
  • Dividend Yield
  • VS N/A
  • LYRA N/A
  • EPS Growth
  • VS N/A
  • LYRA N/A
  • EPS
  • VS N/A
  • LYRA N/A
  • Revenue
  • VS $2,183,196.00
  • LYRA $770,000.00
  • Revenue This Year
  • VS $3,459.21
  • LYRA N/A
  • Revenue Next Year
  • VS N/A
  • LYRA $123.46
  • P/E Ratio
  • VS N/A
  • LYRA N/A
  • Revenue Growth
  • VS 1873.85
  • LYRA N/A
  • 52 Week Low
  • VS $1.00
  • LYRA $3.81
  • 52 Week High
  • VS $9.59
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • VS 49.67
  • LYRA 36.31
  • Support Level
  • VS $1.80
  • LYRA $6.03
  • Resistance Level
  • VS $2.02
  • LYRA $6.90
  • Average True Range (ATR)
  • VS 0.09
  • LYRA 0.40
  • MACD
  • VS 0.03
  • LYRA -0.03
  • Stochastic Oscillator
  • VS 96.55
  • LYRA 21.78

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: